A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy

Phillip H. Kuo; Don C. Yoo; Ryan Avery; Marc Seltzer; Jeremie Calais; James Nagarajah; Wolfgang A. Weber; Wolfgang P. Fendler; Michael S. Hofman; Bernd J. Krause; Marcia Brackman; Euloge Kpamegan; Samson Ghebremariam; Taylor Benson; Ana M. Catafau; Ayse T. Kendi

doi:10.2967/jnumed.122.265077

Research ArticleClinical Investigation

Open Access

A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy

Phillip H. Kuo, Don C. Yoo, Ryan Avery, Marc Seltzer, Jeremie Calais, James Nagarajah, Wolfgang A. Weber, Wolfgang P. Fendler, Michael S. Hofman, Bernd J. Krause, Marcia Brackman, Euloge Kpamegan, Samson Ghebremariam, Taylor Benson, Ana M. Catafau and Ayse T. Kendi

Journal of Nuclear Medicine May 2023, 265077; DOI: https://doi.org/10.2967/jnumed.122.265077

Phillip H. Kuo

1University of Arizona, Tucson, Arizona;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Don C. Yoo

2Warren Alpert Medical School of Brown University, Providence, Rhode Island;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ryan Avery

3Northwestern University, Evanston, Illinois;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marc Seltzer

4Geisel School of Medicine at Dartmouth, Hanover, New Hampshire;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremie Calais

5Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James Nagarajah

6Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang A. Weber

7TUM School of Medicine, Technical University of Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang P. Fendler

8Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael S. Hofman

9Cancer Imaging, Prostate Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;

10Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernd J. Krause

11Rostock University Medical Center, Rostock, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcia Brackman

12Novartis Pharmaceuticals Corporation, Indianapolis, Indiana;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Euloge Kpamegan

13Novartis Pharmaceuticals Corporation, East Hanover, New Jersey;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samson Ghebremariam

13Novartis Pharmaceuticals Corporation, East Hanover, New Jersey;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Taylor Benson

14Novartis Pharmaceuticals Corporation, St. George, Utah;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ana M. Catafau

15Advanced Accelerator Applications, Geneva, Switzerland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ayse T. Kendi

16Mayo Clinic, Rochester, Minnesota

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy

Journal of Nuclear Medicine May 2023, 265077; DOI: 10.2967/jnumed.122.265077

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy

Journal of Nuclear Medicine May 2023, 265077; DOI: 10.2967/jnumed.122.265077

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
Survey of Clinical Protocols for the Use of 177Lu-PSMA-617 in the United States
Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies
The Hierarchy of SUVs: From Diagnostics to Therapeutics and the Pathway to Effective Theranostics

Google Scholar

Keywords

PSMA
prostate cancer
PET/CT

Main menu

User menu

Search

A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords